Neurotoxic events associated with BCR-ABL1 tyrosine kinase inhibitors: a case series.
Hind RafeiElias Joseph JabbourHagop KantarjianKaylyn D SinicropeCarlos Kamiya-MatsuokaRohtesh S MehtaNaval G DaverTapan M KadiaKiran NaqviJorge CortesMarina KonoplevaPublished in: Leukemia & lymphoma (2019)